Ljubicić N, Bilić A
Dept. of Gastroenterology and Hepatology, University of Zagreb, Dr. Josip Kajfes General Hospital, Yugoslavia.
Scand J Gastroenterol. 1991 Jul;26(7):751-7. doi: 10.3109/00365529108998595.
The effects of different types of adrenoceptor blocking agents on portal venous blood flow were studied in 10 patients with liver cirrhosis by using a duplex Doppler system. Oral atenolol (selective beta 1 blocker), propranolol (non-selective beta blocker), and labetalol (non-selective adrenoceptor blocker) were compared. The drugs were administered at random at an interval of 3 days or more. Hemodynamic measurements were done before and after 1 h, 2 h, and 3 h of therapy. Atenolol and propranolol produced significant decrease in the portal vein cross-sectional area, portal blood velocity, and estimated volume of the portal blood flow. The portal blood velocity decreased by 13.1 +/- 7.2% 3 h after atenolol and by 16.2 +/- 6.5% 3 h after propranolol administration (p less than 0.05). Labetalol had no significant influence on portal venous hemodynamics. These results support the hypothesis that a decrease in portal venous flow induced by beta blockers is at least partly mediated with alpha-adrenergic receptors.
通过使用双功多普勒系统,对10例肝硬化患者研究了不同类型肾上腺素能受体阻滞剂对门静脉血流的影响。比较了口服阿替洛尔(选择性β1受体阻滞剂)、普萘洛尔(非选择性β受体阻滞剂)和拉贝洛尔(非选择性肾上腺素能受体阻滞剂)。药物以随机方式给药,间隔3天或更长时间。在治疗前以及治疗1小时、2小时和3小时后进行血流动力学测量。阿替洛尔和普萘洛尔使门静脉横截面积、门静脉血流速度以及估计的门静脉血流量显著降低。服用阿替洛尔3小时后门静脉血流速度降低了13.1±7.2%,服用普萘洛尔3小时后降低了16.2±6.5%(p<0.05)。拉贝洛尔对门静脉血流动力学无显著影响。这些结果支持以下假说:β受体阻滞剂引起的门静脉血流减少至少部分是由α-肾上腺素能受体介导的。